RALGAPA2: A Potential Drug Target Or Biomarker (G57186)

Target Name: RALGAPA2

NCBI ID: G57186

RALGAPA2: A Potential Drug Target Or Biomarker

RALGAPA2 (also known as Akt substrate AS250) is a protein that is expressed in various tissues and cells throughout the body. It is a key regulator of the PI3K/Akt signaling pathway, which is involved in a wide range of cellular processes including cell survival, growth, and angiogenesis. The Akt pathway is a well-established target for many diseases, including cancer, and RALGAPA2 has been identified as a potential drug target or biomarker.

The PI3K/Akt signaling pathway is a complex protein-protein interaction that involves the interaction of several different proteins, including the phosphatidylinositol (PI) molecule, which is a key signaling molecule in the pathway. The Akt protein, which is the protein of interest in this pathway, is a kinase that is activated by the PI3K molecule and then phosphorylates other proteins on the downstream pathway. The Akt pathway is a critical pathway for cell survival and growth, and is involved in the regulation of many cellular processes, including cell adhesion, migration, and angiogenesis.

RALGAPA2 is a protein that is expressed in various tissues and cells throughout the body. It is a 21-kDa protein that is composed of 155 amino acid residues. RALGAPA2 is predominantly expressed in the brain, heart, and pancreas, and is also expressed in other tissues, including muscle and kidney. It is a scaffold protein that is involved in the regulation of the PI3K/Akt signaling pathway.

RALGAPA2 functions as an essential regulator of the PI3K/Akt signaling pathway. It is a key substrate for the Akt protein, which is activated by the PI3K molecule and then phosphorylates other proteins on the downstream pathway. The Akt protein is a 42-kDa protein that is composed of 217 amino acid residues. It is a kinase that is involved in the regulation of many cellular processes, including cell adhesion, migration, and angiogenesis.

The PI3K/Akt signaling pathway is a complex protein-protein interaction that involves the interaction of several different proteins, including the phosphatidylinositol (PI) molecule, which is a key signaling molecule in the pathway. The Akt pathway is a critical pathway for cell survival and growth, and is involved in the regulation of many cellular processes, including cell adhesion, migration, and angiogenesis.

RALGAPA2 is a protein that is expressed in various tissues and cells throughout the body. It is a 21-kDa protein that is composed of 155 amino acid residues. RALGAPA2 is predominantly expressed in the brain, heart, and pancreas, and is also expressed in other tissues, including muscle and kidney. It is a scaffold protein that is involved in the regulation of the PI3K/Akt signaling pathway, which is a critical pathway for cell survival and growth.

In conclusion, RALGAPA2 is a protein that is expressed in various tissues and cells throughout the body. It is a 21-kDa protein that is composed of 155 amino acid residues. RALGAPA2 is a key regulator of the PI3K/Akt signaling pathway, which is involved in the regulation of many cellular processes, including cell adhesion, migration, and angiogenesis. The Akt pathway is a critical pathway for cell survival and growth, and is involved in the regulation of many cellular processes, including cell adhesion, migration, and angiogenesis. Further research is needed to fully understand the role of RALGAPA2 as a drug target or biomarker.

Protein Name: Ral GTPase Activating Protein Catalytic Subunit Alpha 2

Functions: Catalytic subunit of the heterodimeric RalGAP2 complex which acts as a GTPase activator for the Ras-like small GTPases RALA and RALB

More Common Targets